Identification of a novel de novo GATA3 mutation in a patient with HDR syndrome

Liu Chen1, Bing Chen1, Wuilin Leng1

  • 1Department of Endocrinology, First Affiliated Hospital of Third Military Medical University, Chongqing, China.

Insights

This study presents a case of hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome in a young male. A novel GATA3 gene mutation was identified, reinforcing its role in HDR syndrome pathogenesis.

Area of Science:

  • Genetics
  • Nephrology
  • Endocrinology

Background:

  • Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome is a rare genetic disorder.
  • Genetic mutations, particularly in the GATA3 gene, are implicated in HDR syndrome.

Observation:

  • A 21-year-old male presented with hypocalcemia, hyperphosphatemia, limb twitching, deafness, proteinuria, elevated creatinine and urea, and kidney shrinkage.
  • Brain CT revealed intracranial calcifications.

Findings:

  • The patient was diagnosed with HDR syndrome.
  • DNA analysis identified a novel de novo frameshift mutation (c. 529dupC) in the GATA3 gene.
  • This mutation leads to a premature stop codon, suggesting GATA3 haploinsufficiency.

Implications:

  • This case provides further evidence linking GATA3 gene mutations to HDR syndrome.
  • Understanding the genetic basis of HDR syndrome aids in diagnosis and potential therapeutic strategies.
  • Highlights the importance of genetic testing in patients with complex syndromic presentations.

Related Concept Videos